WA
ARKG icon

Waverly Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Waverly Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,428
Closed -$805K – 984
2024
Q3 		$805K Sell
31,428
-1,826
-5% -$46.5K 0.01% 487
2024
Q2 		$781K Sell
33,254
-562
-2% -$14.2K 0.02% 479
2024
Q1 		$973K Hold
33,816
– – 0.02% 374
2023
Q4 		$1.11M Hold
33,816
– – 0.04% 208
2023
Q3 		$942K Sell
33,816
-859
-2% -$28.1K 0.04% 204
2023
Q2 		$1.18M Buy
34,675
+4,825
+16% +$152K 0.05% 171
2023
Q1 		$898K Buy
29,850
+2,700
+10% +$83.7K 0.05% 150
2022
Q4 		$766K Sell
27,150
-791
-3% -$25.1K 0.04% 144
2022
Q3 		$918K Buy
27,941
+9,142
+49% +$336K 0.06% 116
2022
Q2 		$592K Sell
18,799
-3,760
-17% -$131K 0.05% 118
2022
Q1 		$1.04M Hold
22,559
– – 0.09% 77
2021
Q4 		$1.09M Hold
22,559
– – 0.09% 75
2021
Q3 		$1.66M Buy
22,559
+15,989
+243% +$1.34M 0.14% 57
2021
Q2 		$530K Hold
6,570
– – 0.05% 109
2021
Q1 		$518K Sell
6,570
-155
-2% -$15.4K 0.05% 100
2020
Q4 		$746K Sell
6,725
-1,375
-17% -$110K 0.08% 76
2020
Q3 		$532K Hold
8,100
– – 0.07% 83
2020
Q2 		$481K Hold
8,100
– – 0.06% 88
2020
Q1 		$253K Hold
8,100
– – 0.04% 114
2019
Q4 		$286K Hold
8,100
– – 0.04% 112
2019
Q3 		$239K Hold
8,100
– – 0.03% 116
2019
Q2 		$279K Buy
+8,100
New +$260K 0.04% 106

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Waverly Advisors's ARKG Position: Q4 2024 in Review

Waverly Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 31,428 shares — an estimated $805K sold.

Waverly Advisors first reported a position in ARKG in Q2 2019 and held it in 22 quarters. The position peaked at $1.66M in Q3 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Waverly Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Waverly Advisors sold 31,428 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $805K.
  • Waverly Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 22 quarters.
  • Waverly Advisors's ARK Genomic Revolution ETF position peaked at $1.66M in Q3 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Waverly Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.